Evidence map›Paper›PMID 31197741›Full record

ReviewJournal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology2019

Recommendations for

Shinichiro Kumita, Keiichiro Yoshinaga, Masao Miyagawa, Mitsuru Momose, Keisuke Kiso, Tokuo Kasai, Masanao Naya, Committee for diagnosis of cardiac sarcoidosis using 18F-FDG PET, Japanese Society of Nuclear Cardiology

Abstract readReview
PubMed Publisher
In one paragraph

Review in Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 44 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
44citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

44 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Meta-analysis of the effectiveness of heparin in suppressing physiological myocardial FDG uptake in PET/CT.Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology · 2023
    Pooled it
  3. Article
  4. Review
  5. Diagnostics (Basel, Switzerland) · 2025
    Review
  6. Prolonged Fasting Preparation for over 24 Hours BeforeAnnals of nuclear cardiology · 2025
    Article
  7. Article
  8. Review
  9. Cardiomyopathy Associated with CD36 Deficiency: Role ofInternal medicine (Tokyo, Japan) · 2024
    Article
  10. Review
  11. Article
  12. Review
  13. Physiological myocardialAsia Oceania journal of nuclear medicine & biology · 2024
    Article
  14. Review
  15. Right atrial wall inflammation detected byBMC cardiovascular disorders · 2023
    Article
  16. Motion correction for diagnosis of cardiac sarcoidosis-do we have all the answers?Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology · 2023
    Article
  17. Serial assessment of cardiac involvement in sarcoidosis by delayedJournal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology · 2023
    Article
  18. Article
  19. Methotrexate for cardiac sarcoidosis: is it justifiable?Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology · 2023
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Shinichiro KumitaDepartment of Radiology, Nihon Medical University, Tokyo, Japan.
Keiichiro YoshinagaDiagnostic and Therapeutic Nuclear Medicine, National Institutes for Quantum and Radiological Science and Technology, National Institute of Radiological Sciences, 4-9-1 Anagawa, Inage-Ku, Chiba, 263-8555, Japan. yoshinaga.keiichiro@qst.go.jp.
Masao MiyagawaDepartment of Radiology, Ehime University Graduate School of Medicine, Matsuyama, Japan.
Mitsuru MomoseDepartment of Diagnostic Imaging and Nuclear Medicine, Tokyo Women's Medical University, Tokyo, Japan.
Keisuke KisoDepartment of Radiology, National Cerebral and Cardiovascular Center, Osaka, Japan.
Tokuo KasaiDepartment of Cardiology, Niigata University School of Medicine, Niigata, Japan.
Masanao NayaDepartment of Cardiology, Hokkaido University Graduate School of Medicine, Sapporo, Japan.
Committee for diagnosis of cardiac sarcoidosis using 18F-FDG PET, Japanese Society of Nuclear Cardiology

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Fluorodeoxyglucose F18Positron-Emission TomographyRadiopharmaceuticalsCardiomyopathiesHumansJapanPractice Guidelines as TopicSarcoidosisFluorodeoxyglucose F18Radiopharmaceuticals

Identifiers

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.